Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Return on Capital Employed (2016 - 2025)

Rocket Pharmaceuticals' Return on Capital Employed history spans 10 years, with the latest figure at 0.73% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 8.0% year-over-year to 0.73%; the TTM value through Dec 2025 reached 0.73%, down 8.0%, while the annual FY2025 figure was 0.58%, 4.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.73% at Rocket Pharmaceuticals, down from 0.69% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.28% in Q1 2021 and bottomed at 0.73% in Q4 2025.
  • The 5-year median for Return on Capital Employed is 0.52% (2024), against an average of 0.52%.
  • The largest annual shift saw Return on Capital Employed fell -19bps in 2024 before it rose 3bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.34% in 2021, then tumbled by -48bps to 0.5% in 2022, then grew by 3bps to 0.49% in 2023, then crashed by -34bps to 0.65% in 2024, then fell by -12bps to 0.73% in 2025.
  • Per Business Quant, the three most recent readings for RCKT's Return on Capital Employed are 0.73% (Q4 2025), 0.69% (Q3 2025), and 0.66% (Q2 2025).